Members-only Site   |   Print Page   |   Contact Us   |   Sign In   |   Register
Member Alert: Your Presence Needed at CCH 05.21.13
Share |

 


URGENT - ACTION REQUESTED

Tuesday, May 21, 2013

Dear IACP Member:

On Wednesday of this week, the Senate Committee on Health, Education, Labor and Pensions is scheduled to release a revised mark-up of draft legislation that could change compounding pharmacy practice.

IACP and its team of seven full-time lobbyists have worked tirelessly for the past several months on this issue. The extensive series of comments to the original draft Senate HELP bill which we submitted are under serious consideration by the Senate. Even so, the opposition is strong and united and would like to see nothing better than the marginalization of compounding. 

The timing of the mark-up release couldn’t be better for you and your profession because our annual convention – Compounders on Capitol Hill (CCH) – starts the very next week on June 1, 2013. That means we have a unique opportunity to meet face-to-face with our Senate and House representatives to discuss both the positive and the negative aspects of this draft legislation when all the attendees head up to the Hill on Tuesday, June 4. What better way is there to gain support and understanding than to talk and share how this bill could either help or hurt your patients, your business, and your community?

If you haven’t yet registered to attend CCH or maybe you’ve never thought it was an important meeting to attend, NOW IS NOT THE TIME TO SIT BACK AND LET SOMEBODY ELSE DO THE WORK!  

We need your voice to unite with the rest of the compounding community!  


We need you to step up to the plate and help us make sure that compounding pharmacy has a bright future!


We need you at
CCH!  

Here are just some of the key points we’ve already shared with our representatives about this draft bill:


  • The distinction should be clearer in the legislation between a pharmacy or practitioner engaged in compounding for patient care, on one hand, and entities that are engaged in manufacturing for sale and distribution, on the other.
  • Patients must be assured that the compounded medications they receive are regulated effectively and consistently, regardless of whether they are obtained from a local pharmacy or while during hospitalization. That is, a "loophole" should be eliminated from the draft bill that would not hold hospital and health-systems accountable to the same standards.
  • Language in the bill should be adjusted to eliminate confusion and further uncertainty between federal and state law – in particular by including language that recognizes compounding for and dispensing to prescribers for treatment of patients in their offices. The current version, as written, would eliminate both of those critical and necessary activities.
  • Patients must have adequate access to medications that are customized formulations, strengths, or compositions of manufactured drug products. Many patients have unique health conditions that require compounded versions of manufactured drug products that are not available, and new laws or regulations should not hinder that access.
  • The bill should be consistent in its treatment of compounding of drugs for humans and drugs for animals, rather than creating inexplicably disparate standards, rules, and requirements.
  • The bill should actively reaffirm the responsibility of states to oversee traditional physician, pharmacist and veterinarian compounders.

And there will be more as IACP’s team analyzes the revised mark-up.  


While on-line registration for the conference is now closed, you can still register using the onsite registration form and many of our Corporate Partner suppliers have a special discount code to reduce the cost of your registration fee by $50. For additional details on the conference and to reserve your hotel room, visit www.iacprx.org/cch

Be part of the future of compounding by taking action today. Plan to be at IACP’s Compounders on Capitol Hill.  

Sincerely,

   
Wade Siefert, RPh
President
David G. Miller, RPh
Executive Vice President and CEO

Please email iacpinfo@iacprx.org with questions regarding this IACP Member Alert.

 

Stay connected to IACP by joining our online communities!

 

4638 Riverstone Blvd., Missouri City, TX 77459
iacpinfo@iacprx.org | Phone: 281-933-8400 | Toll-Free Referral Line: 800-927-4227
Click here to unsubscribe.
© 2013 International Academy of Compounding Pharmacists. All Rights Reserved.

 

 

 

 

Association Management Software Powered by YourMembership  ::  Legal